News
Holcim schliesst Übernahme von Malarkey Roofing Products ab und erweitert den Bereich Lösungen & Produkte
Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodialysis patients
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220227005069/en/
Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
Notice of ABB’s Annual General Meeting on March 24, 2022
ABB today published the invitation to its Annual General Meeting (AGM), which will be held on Thursday, March 24, 2022. The invitation can be found attached and at www.abb.com/agm.
This press
ABB Publishes 2021 Annual Report
Ad hoc Announcement pursuant to Art. 53 Listing Rules of SIX Swiss Exchange
ABB Ltd published its 2021 annual report and filed the annual report on Form 20-F with the United States Securities and
Swiss Re reports net income of USD 1.4 billion for 2021 and announces ambitious new financial targets
Swiss Re erzielt 2021 Gewinn von 1,4 Mrd. USD und gibt ehrgeizige neue Finanzziele bekannt
Record Results, Strategy 2022 Achieved One Year In Advance
Holcim mit Rekordergebnissen, Strategie 2022 ein Jahr im Voraus umgesetzt
Vifor Pharma reports sustained growth in 2021
Regulatory News:
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Vifor Pharma Group reported a solid performance in 2021 and an increase in profitability, supported by a strong recovery in Ferinject
Vifor Pharma Gruppe erzielt nachhaltiges Wachstum in 2021
Regulatory News:
AD HOC-MITTEILUNG GEMÄSS ART. 53 KR
Die Vifor Pharma Gruppe verzeichnete 2021 eine solide Geschäftsentwicklung und eine Steigerung der Profitabilität, die von einer starken
Accelleron – The New Face of ABB Turbocharging
ABB today announced that its Turbocharging division (PA), a global leader in heavy duty turbocharging for diesel and gas engines, has unveiled its new brand name “Accelleron”, a compound word of
Vifor Pharma gibt Markteinführung von Tavneos® in Deutschland bekannt
Vifor Pharma Deutschland GmbH hat heute die Markteinführung von Tavneos® bekannt gegeben, der ersten in Europa zugelassenen oralen Therapie für die Behandlung der beiden Haupttypen von
Invitation to Dufry's Full Year Results 2021 on March 8, 2022
ABB E-mobility Capital Markets Day 2022: Enabling a Sustainable Future
ABB E-mobility will host its virtual Capital Markets Day today, February 10, 2022, starting at 2pm CET. Frank Mühlon, CEO, and Alex Hall, CFO of ABB’s E-mobility division, as well as other members
New ABB study on industrial transformation unveils critical relationship between digitalization and sustainability
ABB today released the findings of a new global study1 of international business and technology leaders on industrial transformation, looking at the intersection of digitalization and
Holcim-ENGIE-INSA Lyon partner to develop breakthrough energy storage solution
Holcim entwickelt zusammen mit ENGIE und INSA Lyon neuartige Energiespeicherlösung
ABB: Q4 2021 Results
ABB (SWX:ABBN):
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220202005919/en/
KEY FIGURES
Vifor Pharma appoints two new members to the Executive Committee
Regulatory News:
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Vifor Pharma Group today announced the appointment of acting Chief Financial Officer Alexandros Sigalas and Group General Counsel Dr
Significant increase in net profit - Dividend payout ratio increased - New share buy-back programme of up to CHF 400 million
Deutliche Steigerung des Konzerngewinns - Ausschüttungsquote erhöht - Neues Aktienrückkaufprogramm von bis zu CHF 400 Mio.